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Abstract
Background: Birt-Hogg-Dubé syndrome (BHD) is a dominantly inherited familial cancer syndrome characterised by
the development of benign skin fibrofolliculomas, multiple lung and kidney cysts, spontaneous pneumothorax and
susceptibility to renal cell carcinoma. BHD is caused by mutations in the gene encoding Folliculin (FLCN). Little is
known about what FLCN does in a healthy individual and how best to treat those with BHD. As a first approach to
developing a vertebrate model for BHD we aimed to identify the temporal and spatial expression of flcn transcripts
in the developing zebrafish embryo. To gain insights into the function of flcn in a whole organism system we
generated a loss of function model of flcn by the use of morpholino knockdown in zebrafish.
Results: flcn is expressed broadly and upregulated in the fin bud, somites, eye and proliferative regions of the brain
of the Long-pec stage zebrafish embryos. Together with knockdown phenotypes, expression analysis suggest
involvement of flcn in zebrafish embryonic brain development. We have utilised the zFucci system, an in vivo,
whole organism cell cycle assay to study the potential role of flcn in brain development. We found that at
the 18 somite stage there was a significant drop in cells in the S-M phase of the cell cycle in flcn morpholino injected
embryos with a corresponding increase of cells in the G1 phase. This was particularly evident in the brain, retina and
somites of the embryo. Timelapse analysis of the head region of flcn morpholino injected and mismatch control embryos
shows the temporal dynamics of cell cycle misregulation during development.
Conclusions: In conclusion we show that zebrafish flcn is expressed in a non-uniform manner and is likely required for
the maintenance of correct cell cycle regulation during embryonic development. We demonstrate the utilisation of the
zFucci system in testing the role of flcn in cell proliferation and suggest a function for flcn in regulating cell proliferation
in vertebrate embryonic brain development.
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Background
Birt-Hogg-Dubé syndrome (BHD) is a dominantly inher-
ited familial cancer syndrome characterised by the devel-
opment of benign skin fibrofolliculomas, multiple lung
and kidney cysts, spontaneous pneumothorax and
susceptibility to renal cell carcinoma [1, 2]. The syn-
drome results from inactivating mutations in the gene
encoding folliculin (FLCN) [3, 4] which has been
suggested to be a rab35 specific Guanine Nucleotide
Exchange Factor (GEF) [5]. BHD patients only show a
mutation in one copy of the FLCN gene [6], which sug-
gests that several BHD symptoms may be due to abnor-
mal levels of FLCN rather than its complete loss. This
could explain why expression of mutant FLCN has been
seen in a BHD-associated renal carcinoma [7]. FLCN
has been implicated in the regulation of various signal-
ling pathways and cellular processes including cellular
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metabolism through mTOR, AMPK and HIF1α, tran-
scriptional regulation, JAK-STAT signalling, cell adhe-
sion, ciliogenesis, lysosomal biogenesis and autophagy
[7–17]. However, several groups have generated conflict-
ing data on the consequences of FLCN deficiency and
how these lead to the clinical manifestations associated
with BHD is not clear. This leads to the question of what
FLCN does in a healthy individual and how best to treat
those with BHD.
Towards answering this question investigations in a
whole organism model system provide important in-
sights into the nature and evolutionary conservation of
BHD-related effects on target signalling pathways. As
homozygous mutations of Flcn is early embryonic lethal
in mice, rats and dogs [18] , the utilisation of alternative
animal models may be more informative about the de-
velopmental functions of Flcn. The external develop-
ment of zebrafish make it a valuable vertebrate system,
in which to elucidate both the function of flcn and the
molecular pathways of oncogenesis [19].
Here we study the role of flcn in zebrafish develop-
ment using morpholino oligonucleotides to generate a
zebrafish loss of function (LOF) BHD model and we
hypothesise that this could provide insights into the bio-
logical functions of Folliculin. We aim to identify the
temporal and spatial expression of flcn transcripts in the
developing embryo and reconcile this with the pheno-
type associated with the morpholino knock-down of
zebrafish flcn to gain an insight into what flcn may do in
the developing embryo.
Results
Isolation and expression of the zebrafish flcn gene
Based on a sequence search in the zebrafish genome, we
identified flcn (ENSDARG00000062385), a FLCN homo-
log with very high sequence similarity to the human
gene (ENSG00000154803) (Fig. 1a). To address when
and where flcn is expressed we utilized our published
[20] genome level analysis of the zebrafish transcriptome
(by RNA Sequencing (RNASeq) and CAGE sequencing)
and extracted flcn expression information at various
stages of zebrafish development. Zebrafish flcn is
expressed maternally, both in the unfertilized egg and in
the pre MBT embryo. flcn is transcribed by the embryo
during all stages of development at least up to larval
stages. (Fig. 1b and c). We cloned a full open reading
frame of the zebrafish flcn gene product by RT-PCR
from protruding-mouth stage zebrafish larvae and veri-
fied the integrity of the sequence by sequencing and
alignment to the zebrafish genome. To identify the flcn
expression dynamics during embryo development we
conducted whole mount in situ hybridization at several
stages. At the start of gastrulation flcn expression can be
seen at a low level throughout the whole embryo (Fig. 1d)
and this expression remains present at subsequent devel-
opmental stages. In addition at four somite stage there is
increased expression in the region of the tail bud (Fig. 1e
arrow) while at Prim-5 stage there is increased expres-
sion in the myotome border/somatic furrow, eye, hatch-
ing gland (Fig. 1f arrow HG), fin bud (Fig. 1f arrow FB)
tectum (Fig. 1g arrow T) and telencephalon (Fig.1g
arrow TC). At long-pec stage pronounced expression is
detected in a thin layer of cells in the posterior tectum
(Fig. 1h arrow, i and j) and the fin (Fig. 1h). This expres-
sion is compared to that of the proliferating cell nuclear
antigen (pcna) gene, using whole mount in situ
hybridization (Fig. 1k, l and m) where it can be seen that
there is an overlap in the expression of pcna and flcn in
posterior tectum. The overlapping expression in the
posterior tectum can be confirmed by fluorescent
double in situ hybridization of flcn (Fig. 1j and n)
and pcna (Fig. 1m and n). These results suggest that
flcn may play a role in the regulation of the prolifera-
tion of cells in the embryo particularly in the prolifer-
ative zone of the brain.
Morpholino knockdown indicates embryonic functions of
folliculin
To gain insight into the potential role of flcn in cell pro-
liferation in the brain, as suggested by the elevated ex-
pression in the proliferative zones and to interrogate flcn
function in general we applied morpholino antisense
oligonucleotides (MO). These were designed to block
either the translation start site or the mRNA splicing
acceptor site of flcn. The latter is expected to lead to a
retention of an intron and either nonsense mediated
decay or a premature stop of translation and thus to
knockdown Flcn protein expression (Fig. 2a). Efficiency
of morpholino-induced altered splicing of pre-mRNA
and thus gene knockdown was assessed by RT-PCR and
qPCR on total RNA extracted from a pool of injected
embryos. In embryos injected with flcn splice 1 morpho-
lino the RT-PCR product was larger than that seen in
the mismatch control morpholino injected embryos indi-
cating that the 88 bp intron was retained (Additional file
1: Figure S1A). Retention of this intron leads to a prema-
ture stop and thus knockdown of the Flcn protein is ex-
pected. We are currently unable to assess protein levels
as attempts to use mammalian anti-FLCN as well as
newly generated zebrafish Flcn antibodies failed to spe-
cifically recognise zebrafish Flcn protein in Western
blots on embryo extracts (data not shown). In embryos
injected with 100 μM of flcn splice 2 morpholino a prod-
uct was seen when a forward primer in exon 1 and a
reverse primer in intron 1 were used. No product was
seen in uninjected embryos or those injected with
100 μM of mismatch control morpholino (Fig. 2b).
qPCR using primer pairs in exon 1 and primer pairs in
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exon 2 shows a reduction in exon 2 transcripts in
100 μM of flcn splice 2 morpholino injected embryos
when compared with 100 μM mismatch control morpho-
lino injected or uninjected embryos (Fig. 2c). Expression
from embryos injected with 100 μM of flcn exon 2 mor-
pholino was significantly down regulated (higher Ct,
Fig. 2c) compared with uninjected embryos (ΔCt = 0.758,
SE = 0.291, t = 2.61, p = 0.015.). Neither expression from
flcn exon 2 mismatch morpholino-injected embryos (t =
0.141, p = 0.889), nor flcn exon 1 morpholino-injected
embryos (MO, t = 1.30, p = 0.206 and MM, t = 0.407, p =
0.688) was significantly different from uninjected
embryos.
Knockdown of the zebrafish flcn gene by microinjec-
tion of either 100 μM of splice 2 (Fig. 2f, g and i),
100 μM of splice 1 (Additional file 1: Figure S1C) or
600 μM of ATG- targeting (Additional file 1: Figure S1E)
flcn morpholino into wild-type zebrafish embryos re-
sulted in a clear and reproducible phenotype (Additional
file 2: Table S1) while control injected embryo appeared
unaffected. At 18 somite stage embryos injected with
flcn morpholino appeared to show developmental arrest
when compared with mismatch controls. At Prim-5
stage experimental embryos showed a 2 h delay in devel-
opment, with U-shaped somites and non-linear noto-
chord in the tail (Fig. 2f ) and cell death in the brain and
trunk as implied by an increase in Acridine Orange
staining (Fig. 2g), when compared to mismatch control
morpholino injected embryos (Fig. 2d and e). At Long-
pec stage the phenotype was characterised by brain
oedema and problems with tail circulation as well as lar-
ger yolk and thinner yolk extension (Fig. 2i, Additional
file 1: Figure S1D and S1F) when compared to mismatch
controls (Fig. 2h and Additional file 1: Figure S1C and
S1E) which were indistinguishable from the uninjected
embryos.
To confirm that the morphant phenotype is caused by
reduced gene expression of flcn, we aimed to perform
rescue experiments by injection of the flcn splice 2 mor-
pholino and full-length flcn RNA. Therefore, the full
open reading frame of zebrafish flcn was cloned into the
pCS2+ vector and RNA was produced in vitro. As injec-
tion of flcn RNA into mismatch morpholino injected
embryos resulted in an increased number of embryos
showing cyclopia, heart oedema, circulatory defects and
reduced axis, rescue of MO knockdown was assessed by
abolishment of the hydrocephalus and yolk phenotype.
Increasing the amount of flcn RNA in embryos injected
with flcn splice 2 morpholino resulted in an increase in
the number of embryos that were phenotypically normal
and a decrease in the number of embryos showing a
severe hydrocephalus and yolk phenotype (Fig. 2j). These
results suggest that the flcn morpholino is specifically
targeting the flcn transcripts and that flcn may be
required for the development of the zebrafish embryo
particularly in the growing brain.
flcn morphants do not show kidney defects or defects in
motile cilia in early development
As BHD patients have an increased risk of developing
renal cysts and tumours [2] we decided to study the
effect of flcn knockdown on kidney development in
zebrafish embryos. The Wilms Tumor-1b GFP trans-
genic line (Tg(wt1b:EGFP)) expresses GFP exclusively
in the pronephros and exocrine pancreas [21]. Injec-
tion of flcn morpholino into Tg(wt1b:EGFP) did not
reveal any obvious defects in pronephric development at
Long-pec stage (Additional file 1: Figure S1H) when com-
pared with mismatch control injected (Additional file 1:
Figure S1G)
Morpholino knockdown of flcn in zebrafish resulted in
a phenotype reminiscent of ciliary gene mutants [22]
(See figure on previous page.)
Fig. 1 Conservation and expression of zebrafish flcn. a Comparative alignment of human flcn and zebrafish flcn protein sequence using Clustal
Omega. (*) indicates positions which have a single, fully conserved residue, (:) indicates conservation between groups of strongly similar
properties (.) indicates conservation between groups of weakly similar properties, Red = Small (small + hydrophobic), Blue = Acidic, Magenta = Basic –
H, Green = Hydroxyl + sulfhydryl + amine + G and Grey = Unusual amino/imino acids. b Graph showing CAGE CT values for the zebrafish flcn gene
over time, where CT values are the sum of all CAGE detected Transcription Start Site (CTSS) values , representing the number of cage tags (initiation
instances) occurring at the same base (normalized tags per million (tps)) in the flcn promoter region. The count value was normalized according to
total mapped tags and CTSS instances. c Graph showing the RNAseq RPKM values for zebrafish flcn over time, where the RPKM values
represent the mean of the signal coverage value in the promoter region, therefore the sum of the total signal in the whole gene locus
region divided by the number of bases with coverage. d Shield stage embryo showing ubiquitous expression. e 4 somite stage embryo
showing low level expression over the whole embryo with increased expression seen in the region of the tail bud (arrow). f Prim-10
stage embryo showing low level expression in the whole embryo with more pronounced expression in the forebrain and hindbrain areas,
hatching gland (HG, arrow) and the fin bud (FB, arrow). g Head of Prim-10 stage embryo showing expression in the tectum (TC) and
telencephalon (T) (arrows). h Long-pec stage embryos showing expression in the brain (arrow) and retina of the embryo. i Long-pec
stage embryo showing pronounced expression in the posterior tectum of the brain (arrow). j Head region of a Long-pec stage embryo
showing expression of flcn (green) in the posterior tectum. k Long-pec stage embryo showing pcna expression in the retina and brain
(arrow). l pcna expression in the posterior tectum of a Long-pec stage embryo (arrow) (m) head region of the same Long-pec stage
embryo as panel J showing pcna (red) in the posterior tectum (n) head region of a Long-pec stage embryo showing expression of both
pcna (red) and flcn (green) with co-localisation (yellow) in the posterior tectum (n = 20 embryos for all WMISH)
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Fig. 2 Knockdown of flcn in zebrafish embryos. a Schematic from the UCSC genome browser showing the binding sites of the ATG and splice
site morpholinos used to knockdown the flcn gene (yellow box) (b) Electrophoresis gel showing; amplified flcn exon 1 and flcn exon 2 transcripts
in wild type (WT), 100 μM of mismatch morpholino injected (sp2 MM) and 100 μM of flcn splice 2 morpholino injected (sp2 MO) embryos and;
amplified flcn exon 1 to intron transcripts in 100 μM of flcn splice 2 morpholino injected embryos (sp2 MO) with no transcript in wild type (WT)
and 100 μM of mismatch morpholino injected (sp2 MM) embryos (c) Box-whisker plots of flcn qPCR. Results, ΔCt, indicate expression relative to
uninjected embryos. Boxes denote interquartile range with central horizontal line showing median expression. Whiskers extend to 1.5 x interquartile
range. MO=morpholino, MM=mismatch. d Prim-5 stage 100 μM control splice 2 mismatch morpholino injected embryo. e Prim-5 stage 100 μM
control splice 2 mismatch morpholino injected embryo stained with Acridine Orange f Prim-5 stage 100 μM flcn splice 2 morpholino injected embryo
(g) Prim-5 stage 100 μM flcn splice 2 morpholino injected embryo stained with Acridine Orange (h) Long-pec stage 100 μM control splice 2 mismatch
morpholino injected embryo. i Long-pec stage 100 μM flcn splice 2 morpholino injected embryo. j Proportion of embryos that are normal (Red), show
mild hydrocephalus, larger yolk and thinner yolk extension (blue) or severe hydrocephalus, enlarged yolk and very thin yolk extension (green) when
injected with combinations of 100 μM flcn splice 2 morpholino and 50 pg/μl, 100 pg/μl or 200 pg/μl of flcn RNA. With increasing concentrations of
RNA, there was as significant decrease in the proportion of severe hydrocephalus and corresponding increase in the proportion of normal phenotype
(ordinal logistic regression, n = 3 where n is the number of independent injections at each concentration and p = 0.027)
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and morphants [23]. In addition, BHD in humans was
recently described as a novel ciliopathy [7]. However, no
clear difference in acetylated alpha tubulin staining (a
known ciliary marker) in the pronephros and central
canal cilia was observed at this magnification in Prim-5
stage embryos injected with flcn morpholino (Additional
file 1: Figure S1J) when compared with mismatch con-
trol injected embryos (Additional file 1: Figure S1I).
Cell cycle defects in brain development in flcn morphant
embryos
The lack of obvious defects in motile cilia morphology
and a lack of defects in the developing kidney prompted
us to examine other cellular processes that might be
affected by Flcn deficiency, thereby causing the mor-
phant phenotype. In vitro, FLCN has been implicated in
cell cycle regulation via late S and G2/M phase and cyc-
lin D1 [12, 24, 25]. In addition, the flcn morphants show
developmental arrest and flcn is expressed in the prolif-
erative zone of the brain. Therefore, we decided to
examine cell cycle regulation in more detail in these
zebrafish embryos.
To this end we exploited a novel, powerful in vivo
labelling tool to monitor cell cycle regulation in zebra-
fish embryos after flcn knockdown. The zFucci system
[26] is composed of two transgenes that fluorescently
label G1 (red) and S-M phase (green) nuclei in the living
zebrafish embryo at remarkable spatial and temporal
resolution. The system is based on the detection of ubi-
quitination of fluorescent fusion proteins Cdt1 with
monomeric Kusabira Orange2 and Geminin with mono-
meric Azami Green. zFucci double transgenic embryos
were injected with flcn morpholino or mismatch control
morpholino and reporter activities indicative of S-M
(green) and G1 (red) phases were monitored. Snapshots
of green and red fluorescence were used to evaluate the
status of cell cycles at approximately 18 somite stage.
This analysis indicated a significant drop in the number
of cells in S-M phases (Fig. 3i) in flcn morpholino
injected embryos (Fig. 3e, f, h) particularly in the retina
and various compartments of the brain including the
tectum when compared with mismatch control morpho-
lino injected embryos (Fig. 3a, b, d). A corresponding in-
crease in G1 cells (Fig. 3j) in flcn morpholino injected
embryos (Fig. 3g) was seen when compared with mis-
match control morpholino injected embryos (Fig. 3c).
This argues against general cell death as the reason for
decreased detection of S-M phase cells and suggests
instead a disruption of the cell cycle in the brain as a
result of Flcn knockdown.
Next we asked, whether the change in cell cycle behav-
iour can be attributed to a specific stage of development.
To this end, time-lapse analysis of the head region
(Fig. 4a yellow box) in flcn morpholino injected (Fig. 4g,
h, i and j) and mismatch control (Fig. 4c, d, e, and f ) em-
bryos was carried out over the period from 6 somites to
Prim-20 stages by time lapse confocal microscopy on
immobilised embryos. The time-lapse analyses show that
initially embryos carry comparable levels of cells in G1
phase (Fig. 4b). As time progresses the rates of zFucci
transgene activities diverge suggesting divergence in the
number of S-M and G1 cells respectively (Fig. 4b) and a
gradual increase in cells in G1 phase in flcn morpholino
injected embryos when compared to mismatch control
injected embryos (Fig. 4b). These results suggest that
there is no specific stage with dramatic change in cell
cycle behaviour, but rather indicates a gradual loss of
proliferation of the cells monitored by the zFucci
system.
Discussion
In this study we show the result of gene expression ana-
lysis and morpholino knockdown of flcn during zebrafish
early development. Our results suggest that flcn may be
required for zebrafish embryonic brain development.
Interestingly Birt-Hogg-Dubé (BHD) patients shown no
defects in the brain however all known BHD patients
only show a mutation in one copy of the FLCN gene [6].
Canine and murine animal models homozygous for
FLCN knockout show early embryonic lethality [27, 28].
Chen et al. and Hasumi et al. showed that mice homozy-
gous for flcn mutation die between 3.5 dpc and 8.5 dpc
[9] (E5.5–E6.5 [18]). Before death mutant mice lacked
an organised epiblast and surrounding visceral endo-
derm. In embryos that did develop visceral endoderm
and ectoderm, these layers had a disorganised structure
containing cells with an enlarged cytoplasm and disor-
ientated nuclei. In contrast flcn morpholino injected zeb-
rafish, appear to develop normally past gastrulation with
the first signs of disruption occurring when the embryos
arrest at 18hpf. By Prim-5 stage the embryos exhibit cell
death in the brain and trunk and by Long-pec stage the
embryos show brain oedema and problems with tail cir-
culation as well as a larger, more fragile yolk and thinner
yolk extension.
The morpholino phenotype is supported by whole
mount in situ hybridization of flcn showing expression
in the tectum and telencephalon in zebrafish. In mice,
flcn expression can be seen in the neural tube [18]. At
E7.5 Flcn showed a strong signal in the neural ectoderm
of the primitive streak region and in the headfold of the
ectoderm in mice. At E9.5, Flcn was expressed almost
ubiquitously with a strong signal in the neural tube and
optic pit. However, at E10.5 Flcn was highly expressed in
the branchial arch, forelimb, and hind limb, as well as in
the somites. Adult mice showed expression in the heart,
pancreas and prostate with moderate expression in adult
brain, kidney, liver and lung [18]. These results appear
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consistent with what we see in zebrafish development
where expression of flcn is also seen in the fin bud,
somites, eye and regions of the brain. This suggests a
critical role for flcn in vertebrate development.
In humans BHD has recently been described as a
novel ciliopathy with FLCN being shown to localise to
motile and non-motile cilia, centrosomes and the mitotic
spindle. Alteration of FLCN levels caused changes to the
onset of ciliogenesis [7]. In zebrafish embryos lacking
genes important for ciliogenesis one of the reported
phenotypes is hydrocephalus [29], also seen in flcn mor-
phants [30]. It therefore seemed probable that knock-
down of flcn in zebrafish embryos would result in
defects in the pronephros and/or other ciliated
structures. However we have found no evidence for this
when we compare the pronephros of Tg(wt1b:EGFP)
zebrafish embryos with and without flcn knockdown or
when using immunofluorescent staining for acetylated
alpha tubulin (a ciliary marker). It is possible that
although cilia seem to be present in the flcn knockdown
embryos, they may not be functional. Alternatively,
mammalian FLCN is present in both motile and non-
motile cilia [7]. In this study we primarily focused on
the effect of flcn morpholino knockdown on the
appearance of motile cilia, as it has been shown that
defects in these cilia can cause hydrocephalus and
kidney cysts [23, 31, 32]. However aspects of the flcn
morpholino phenotype such as hydrocephalus and cell
Fig 3 Cell cycle defects in flcn morphant embryos at 18 somite stage of development. Zebrafish Fucci embryo injected with flcn sp2 mismatch
control morpholino imaged in (a) Brightfield, (b) fluorescence for Geminin-Azami Green (S/G2/M phase), (c) fluorescence for Cdt1-Kusabira
Orange2 and (d) fluorescence merge of Geminin-Azami Green (S/G2/M phase) and Cdt1- Kusabira Orange2 (G1). Zebrafish Fucci embryo injected
with flcn sp2 morpholino imaged in (e) Brightfield, (f) fluorescence for Geminin-Azami Green (S/G2/M phase), (g) fluorescence for Cdt1-Kusabira
Orange2 and (h) fluorescence merge of Geminin-Azami Green (S/G2/M phase) and Cdt1- Kusabira Orange2 (G1). i Pixel intensity of
Geminin-Azami Green in embryos injected with flcn sp2 mopholino injected embryos (solid green line (MO)) when compared with flcn
sp2 mismatch control morpholino injected embryos (dashed green line (MM)). Green lines show empirical log(intensity) data distributions.
j Pixel intensity of Cdt1-Kusabira Orange2 in embryos injected with flcn sp2 mopholino injected embryos (solid red line (MO)) when
compared with flcn sp2 mismatch control morpholino injected embryos (dashed red line (MM)). Red lines show empirical log(intensity)
data distributions. Vertical, black lines indicate means, with parameter confidence distributions shown as curved black lines. Vertical, black
lines indicate means, with parameter confidence distributions shown as curved black lines
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cycle defects could also be explained by defects in the
non-motile primary cilia, [33, 34] providing interest-
ing avenues for further investigations. Alternatively,
FLCN’s function in ciliogenesis may be specific to
mammals.
Given the lack of obvious ciliary defects we sought to
understand the developmental arrest phenotype. In par-
ticular whether this phenotype was caused by defects in
the cell cycle as a recent study by Laviolette et al. (2013)
suggested that flcn delays cell cycle progression through
late S and G2/M phase [25]. To do this we knocked
down flcn in zFucci transgenic embryos where the G1
phase of the cell cycle is labelled red and S, G2 and M
are labelled green. We found that at the 18 somite stage
there was a significant drop in S-M states (Fig 3j) and a
corresponding increase in G1 cells in flcn morpholino
injected embryos (Fig 3e, f, h). This was particularly
evident in the brain, retina and somites of the embryo,
areas that have been shown in both mice [18] and zebra-
fish (Fig 1) to express flcn. To investigate at which devel-
opmental stage this divergence of zFucci transgene
activities arises we undertook timelapse analysis of the
head region of flcn morpholino injected and mismatch
control embryos which show a gradual and increasing
change over time. From this we can conclude that Flcn
may play a role in the cell cycle. However, the exact
nature of Flcn's control on the cell cycle remains to be
determined, as recent in vitro studies have suggested
that FLCN delays cell cycle progression through late S
and G2/M phase [25] and that FLCN regulates cyclin D1
expression [24] which promotes G1 to S phase progres-
sion in the cell cycle [35]. Kawai et al. found that RNAi
knockdown of FLCN in HeLa cells led to increased cyc-
lin D1 expression and, conversely, that reintroduction of
Fig. 4 Cell cycle defects in flcn morphant embryos during somitogenesis. a Zebrafish Fucci embryo showing fluorescence for Cdt1-Kusabira
Orange2 (G1 phase) with analysed region of the head indicated by yellow box. b Longitudinal time courses of log(intensity) of pixels from 3 flcn
splice 2 mismatch morpholino and 4 flcn splice 2 morpholino injected embryos. Frames were taken at 22 min and 36 s intervals from bud stage
for flcn splice 2 mismatch morpholino and 2-somite stage for flcn splice 2 morpholino injected embryos. Red data points represent flcn sp2
morpholino (MO) injected embryos; black data points represent mismatch control morpholino (MM) injected embryos. Solid lines indicate
estimated mean trajectories for each treatment group, with dashed lines denoting parameter 95 % confidence intervals. c Bud stage,
(d) 2-somite stage, (e) 4-somite stage, (f) 10-somite stage flcn splice 2 mismatch control morpholino injected embryos. g 2-somite stage,
(h) 4-somite stage, i 6-somite stage, (j) 10-somite stage flcn splice 2 morpholino injected embryos
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the FLCN gene into FLCN-null Nihon rat kidney tumour
cells reduced cyclin D1 expression. They surmised that
these results suggested that FLCN inhibits cyclin D1 ex-
pression and, by extension, may also regulate G1 to S
phase transition of the cell cycle. Conversely in zebrafish
we found that knockdown of flcn resulted in no signifi-
cant change in cyclin D1 (data not shown) suggesting
that cell cycle defects in the developing embryo as a
whole are likely to be more complex.
Alternatively, the cell cycle defects might be secondary
to other consequences of Flcn knockdown. Cells in G1
can only progress if sufficient growth factors such as
nutrient supply are present (reviewed [36]). In vitro,
FLCN has been shown to regulate signalling of AMPK, a
major sensor of energy status. FLCN directly interacts
with AMPK [8] and loss of FLCN was shown to consti-
tutively activate AMPK leading to mitochondrial biogen-
esis and HIF-driven aerobic glycolysis [17, 37]. Lui et al.
(2013) have shown that Drosophila melanogaster with a
genomic deletion of the Flcn gene never survive to
adulthood and show characteristics of malnutrition [38].
Zebrafish flcn morpholino injected embryos show large,
fragile yolks and thin yolk extensions indicative of de-
fects in nutrient supply and digestive problems [39–41].
It is therefore possible that the phenotype we see is a re-
sult of the zebrafish being unable to properly utilise its
nutritional reserves.
Recent publications have shown that morpholino ana-
lysis may often not be corroborated by genetic mutants
generated by reverse genetic approaches [42, 43]. The
reason for this is unclear and has been suggested to be
due to off target effects of the morpholino or hypo-
morphic alleles in the mutants. However new data by
Rossi et al. may shed some light on this [44]. Rossi et al.
generated mutations in the zebrafish egfl7 gene, which
showed no obvious phenotype. This was in contradiction
to the severe vascular defects seen in wild type embryos
injected with an egfl7 morpholino. After comparing the
proteome and transcriptome of these mutant and mor-
phant embryos they found a number of proteins and
genes which were upregulated in the mutants but not
the morphants. Amongst these were genes that could
rescue the morphant phenotype. This could argue for a
compensatory network that buffers against deleterious
mutations [44].
Morpholino studies – including ours – are supported
by controls including mismatch MO injection and
mRNA rescue experiments [45]. Since the specific phe-
notypes we describe are observed by the targeting MO
only and the hydrocephalus and yolk phenotypes are res-
cuable by MO resistant mRNA, it is reasonable to
speculate that the observed defects are a combination of
a morpholino induced state (such as stress), which gen-
erates a yet unexplained embryo environment, in which
the targeted flcn gene becomes limiting for normal
development. In this morpholino injected environment
the defects observed are due to the loss of the targeted
flcn gene. The controls indicate that the defects cannot
be attributed to flcn-independent off target effects and,
therefore, this loss of function approach remains inform-
ative about linking flcn function to cell cycle regulation
during development. Evidence from cell culture experi-
ments suggests hypomorphic effects of FLCN [7], while
mouse knockouts die in early development prohibiting
meaningful phenotype analyses. Thus our morpholino
knockdown study provides an informative starting point
to unravel the function of flcn in a whole organism ver-
tebrate system. How exactly flcn affects development
and the cell cycle will be answered by the future gener-
ation of flcn mutant embryos. As flcn is known to have
multiple interacting proteins [8, 46–51], we can not rule
out that flcn mutants may employ a compensatory net-
work to buffer against loss of flcn, a result that would
also provide exciting new avenues of investigation.
Conclusions
In conclusion we show that zebrafish flcn is expressed
during embryonic development with elevated expression
levels in proliferating tissues of the zebrafish embryo.
Using flcn knockdown coupled with a whole organism
based in vivo cell proliferation assay we show that flcn is
likely required for embryonic brain development and
that it affects the normal progression of the cell cycle
particularly in the growing brain and suggest a previ-
ously undescribed role for flcn in vertebrates.
Methods
Zebrafish husbandry and embryo generation
Zebrafish embryos were obtained from sibling crosses from
adult AB fish housed at the fish facility at Birmingham
University. Zebrafish were raised and bred and embryos
staged following standard protocols [52, 53]. Embryos are
raised at 28.5 °C. When needed to prevent pigment forma-
tion, embryos were raised in 0.003 % phenylthiocarbamide
in E3 medium (1 mM NaCl, 0.17 mM KCl, 0.33 mM
MgSO4.7H2O, 0.33 mM CaCl2.2H2O) from tailbud stage.
flcn cDNA cloning and mRNA production
The full open reading frame for zebrafish flcn was cloned
from total RNA extracted from pooled protruding-mouth
stage AB* wild type embryos using TRIZOL reagent ac-
cording to manufacturers’ instructions. Next, cDNA was
produced using M-MLV Reverse Transcriptase, RNase H
Minus, Point Mutant (Promega M3681, M3682, M3683)
and oligodT primers (Invitrogen). Zebrafish flcn cDNA
was amplified using the following forward primer with
BamHI restriction site: AATA GGATCC ATGAACGCT
TTAGTTGCCCTG and reverse primer with Xba1
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restriction site: AATA TCTAGA CCCGCTTTCAGT
CTCTCTCAC and cloned into pCS2+ using BamHI (New
England Biolabs) and XbaI (New England Biolabs). Plas-
mid was verified by sequence analysis.
Capped RNA was synthesised using 5 μg (5 μl) of NotI
linearised flcn DNA using SP6 mMESSAGE mMA-
CHINE kit (Ambion). The RNA was cleaned using
GenElute™ Mammalian Total RNA Miniprep Kit (Sigma
RTN70) as per manufacturer’s instructions Appendix 2.
Microinjection of embryos with RNA and morpholino
Morpholino Oligonucleotides (GeneTools) sequences are
as follows:
FLCN ATG MO
AGGGCAACTAAAGCGTTCATCTGTG
FLCN splice1 MO
ATGACACTCCCCTCTCGCTCACCTC
FLCN splice1 MM
ATcACAgTCCCCTgTCGCTgACgTC
FLCN splice2 MO
CGTTCATCTGGAGGAAACAAACATA
FLCN splice2 MM
CGTTCtTgTGcAGGAtACAAAgATA
Morpholinos were diluted in MO buffer (5 mg/ml
phenol red (Sigma), 4 mM HEPES pH 7.2 (Sigma),
160 mM KCl (Sigma)) and 1.4 nl of MO solution was
injected into the yolk of the 1 cell stage embryo. RNA
was diluted to 100-300 pg/μl in nuclease free water and
1.4 nl was injected into the cell of the 1 cell stage em-
bryo. Embryos were stage matched, anaesthetised using
0.016 % MESAB in E3 embryo medium and imaged with
a Nikon SMZ800 stereo microscope and Canon Eos
1100D camera and software.
Quantitative and RT-PCR analysis of splicing morpholino
injected embryos
Total RNA was extracted using TRIZOL according to
manufactures’ instructions. For RT-PCR RNA was
extracted from 50 pooled Long-pec AB* WT embryos
either uninjected or injected with either 100 μM control
splice 1 mismatch morpholino or 100 μM flcn splice 1
morpholino. For qPCR RNA was extracted from 30
pooled Prim5 Nacre WT embryos either uninjected or
injected with either 100 μM of control splice 2 mismatch
morpholino or 100 μM of flcn splice 2 morpholino.
Following DNAse treatment using TURBO DNA-free™
Kit (Ambion AM1907), 1 μg total RNA was subjected to
RT-PCR using M-MLV Reverse Transcriptase, RNase H
Minus, Point Mutant (Promega M3681, M3682, M3683)
and random hexamers (Fermentas SO142). Specific PCR
was performed on 5 μl cDNA using GoTaq polymerase
(Promega M300) with the following primers: Splice 1
forward 5’TCCCATCACATGACACACAA3’, Splice 1 re-
verse 5’GAGACTGCGCACACATGC3’ Exon 1 forward
5’CCCATCACATGACACACAAGA3’, Exon 1 reverse
5’TGCATGTTCATCAGCCTTCC3’, Exon 2 forward
5’TGTTTTGTACCGAAGCCGTC3’, Exon 2 reverse
5’CTCACACATGTCCGCTCTCT3’, Exon 1 to Intron
Forward 5’TTGCCATTGTCAACGCTTTG3’ and Exon
1 to Intron Reverse 5’AACTGCGAGATATCCAGCCA3’
and the following parameters 95 °C for 5 min, (95 °C for
30 s→ 58 °C for 30 s→ 72 °C for 30 s) x34 and 72 °C
for 5 min. qPCR was performed using FastStart Univer-
sal SYBR Green Master (Roche) and primers Exon 1
Forward, Exon 1 Reverse, Exon 2 Forward and Exon 2
Reverse above and control gene primers β-Actin F
CGAGCTGTCTTCCCATCCA, β-Actin R TCACCAA
CGTAGCTGTCTTTCTG, Rpl13α F TCTGGAGGACT
GTAAGAGGTATGC and Rpl13α R AGACGCACAA
TCTTGAGAGCAG [54] on a Stratagene Mx3000P
qPCR machine.
Whole-mount in situ hybridization, double fluorescent
whole-mount in situ hybridization and
immunohistochemistry
Whole-mount in situ hybridization was carried out as
described by Thisse and Thisse [55]. The flcn gene probe
was transcribed directly from cloned cDNA in pCS2+,
linearized with NotI (NEB) and transcribed with T7
polymerase (Promega) using Dig labelling mix (Roche).
The pcna gene probe was transcribed from a plasmid
gifted by F. van Eeden, linearized with Not1 (NEB) and
transcribed with SP6 (Promega) using Dig labelling mix
(Roche). Pre tail bud embryos were fixed in 4 % parafor-
maldehyde overnight and then manually dechorionated.
Embryos older than Prim-5 stage were manually dechor-
ionated and then fixed in 4 % paraformaldehyde over-
night at 4 °C. Embryos were cleared in glycerol and
imaged with a Nikon SMZ800 stereo microscope and
Canon Eos 1100D camera and software and a Zeiss Axio-
plan compound microscope and Axiovision software.
Double fluorescent whole mount in situ hybridization
was carried out as described by [56]. The flcn gene probe
was transcribed as described above and the pcna gene
probe was transcribed as described above but labelled
with DNP labelling kit (Perkin Elmer). pcna was devel-
oped with anti-DNP-POD (1:300) and revealed with
Tyramide-Cy3 at a concentration of 1/25. flcn was devel-
oped with anti-DIG-POD (1:300) and revealed with
Tyramide-FITC at a concentration of 1/150
Whole mount immunofluorescence of acetylated alpha
tublin was carried out as follows: embryos were injected
with either flcn splice 2 morpholino or mismatch mor-
pholino, stage-matched at Prim-5 stage, manually
dechorionated and fixed in 4 % formaldehyde in PBS
overnight at 4 °C. Embryos were permeabilised using
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10 μg/ml proteinase K (Sigma P4850) in PBS containing
0.1 % tween (PBST) for 20 min at room temperature,
followed by re-fixation for 20 min. Non-specific binding
sites were blocked by incubation in 10 % newborn calf
serum in PBS for 1 h at room temperature, followed by
overnight incubation at 4 °C in mouse acetylated alpha
tublin antibodies (abcam 24610) diluted 1:200 in block
buffer. The following day embryos were washed 4x
30 min in PBST and re-blocked for 1 h. Embryos were
incubated in sheep-anti-mouse cy3-conjugated anti-
bodies (Sigma C2181) diluted 1:200 in block buffer over-
night at 4 °C, followed by 4x 30 min wash in PBST.
Embryos were refixed in 4 % formaldehyde in PBS for
20 min at room temperature. Embryos were mounted in
Vectashield (Vector labs) and images captured using a
Leica LSI TCS Zoom confocal and Leica software.
Images were processed using ImageJ software (NIH).
Acridine orange staining
Twenty four hour post fertilisation Nacre embryos were
incubated in 1 μg/ml Acridine Orange (Sigma A6014) in
E3 for 30 min. Embryos were washed, anaesthetised and
imaged under fluorescent light on a Leica MZ10 Stereo
microscope with Jenoptik ProgRes camera.
Embryo preparation and Confocal Imaging
For confocal imaging of zebrafish Fucci embryos [57]
were injected with either 100 μM flcn splice 2 mismatch
morpholino or 100 μM flcn splice 2 morpholino.
Embryos were maintained at 28 °C in Danieaus solution
(58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM
Ca(NO3)2, 5.0 mM HEPES pH 7.6) until bud-stage. A
96-well plate (Greiner Bio-One) was prepared by adding
50 μl of 1 % agarose (Bioline, cat. no. BIO-41025) in
Danieaus solution covered by 30 μl of ethanol (VWR) to
each well and inserting a brass 96 pin spotter (diameter
0.7 mm) into the plate until the agarose set when the
spotter was removed and the plate washed thoroughly
with distilled water. Embryos were dechorinated on 1 %
agarose in Danieaus solution and transferred with 60 μl
of Danieaus in to the 96 well agarose plate. Embryos
were oriented using a Microlance 3 needle outer diam-
eter 0.51 mm (BD Biosciences). 40 μl of mineral oil
(Sigma, cat. no. M5904) was added over the surface of
the Danieaus solution. Leica LSI TCS Zoom confocal
and software was used to record the time-lapse video.
Time-lapse was conducted in xyzt mode using the
532 nm and 488 nm lasers. 40 slices were taken for each
stack for 11 h, z volume 358.395 μm lens 5x, optical
zoom 1.362 step size 9.19, red gain 1200 offset -4, frame
average 4 green gain 1250, offset -5 frame average 8.
Frames were taken at 22 min 36 s intervals from bud
stage for flcn splice 2 mismatch morpholino and 2-
somite stage for flcn splice 2 morpholino injected
embryos. For analysis maximum projection images were
prepared, pixel intensities were manually identified in
the selected area for all embryos. For still imaging, 3
slices were taken for each image with a frame average 3,
2x lens, z volume 500 μm maximum projections were
produced and analysed.
Confocal imaging of Tg(wt1b:EGFP)
Tg(wt1b:EGFP) embryos injected with flcn splice 2 mor-
pholino or flcn splice 2 mismatch morpholino were stage
matched anaesthetised and imaged on a Leica TCS LSI
confocal. Images were processed using ImageJ.
Statistics
Reporter activity
Analysis of zFucci reporter activity was carried out by
statistical evaluation of pixel intensities of fluorescence
signals detected for red and green reporters in flcn splice
2 morpholino injected embryos, compared to mismatch
controls where a mean of 25 embryos were analysed
from each set of injections for 4 independent sets of in-
jections. Mean log pixel intensity was calculated for each
imaged embryo. This was performed for red and green
channels separately. We tested the hypothesis of differ-
ential intensity associated with either flcn MO or control
MO using a linear mixed-effects modelling framework
[58]. Morpholino treatment was fitted as a categorical
fixed effect and other sources of experimental variation
(day, parental fish) were modelled as multilevel random
effects. Treatment contrasts were tested using t-tests
and results were validated by generating parameter con-
fidence distributions using MCMC with 104 iterations.
(R package: lme4. [59])
Time course analysis
Log-transformed intensity data from 3 flcn mismatch MO
injected and 4 flcn splice 2 MO injected embryos was
modelled using Generalised Additive Models, within a
mixed-effects modelling framework. Cubic smoothing
splines were used to model mean trajectories for each
morpholino treatment. Following initial visual inspection,
biological variation was modelled with separate parame-
ters for each morpholino. A first order autoregressive
process was used to model temporal autocorrelation
within each time course. (R package: mgcv. [60])
Rescue experiment
Following replicate (n = 3, mean number embryos per
group = 80) sets of injections with different RNA con-
centrations; phenotypes were categorised as ‘severe’ or
‘mild’ hydrocephalus, or ‘normal’. The proportion of the
population showing each of these phenotypes with in-
creasing inject RNA concentration was modelling using
ordinal logistic regression (R package: MASS. [61]).
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qRT-PCR analysis
Quantitative PCR data from morpholino-injected em-
bryos were normalized against mean expression of two
housekeeping genes (β-actin and Rpl13α [54]). Normal-
ized expression data were analysed using a linear mixed
effects model. Morpholino (morpholino, MO, vs. mis-
match, MM) and exon (1 versus 2) were fitted as inter-
acting fixed effects; with technical replication (n = 3),
explicitly nested within biological replication (n = 3),
fitted as random effects. Fixed effects were assessed
using likelihood ratio tests. Model residuals were found
to meet with assumptions of Normality and homogen-
eity of variance..
All statistical analysis was performed using R, version
3.02 [62]
Animal ethics statement
Animals were raised as per Home Office guidelines and
all experiments were in accordance with Home Office
Animals (Scientific Procedures) Act 1986.
Additional files
Additional file 1: Figure S1. Knockdown of flcn and its effect on cilia
and kidney development in Long-pec stage embryos. (A) Electrophoresis
gel comparing the size of an amplified flcn transcript in wild type (WT)
embryos, embryos injected with flcn splice 1 mismatch morpholino
(sp1 MM) and embryos injected with flcn splice 1 morpholino (sp1 MO).
(B) Comparative alignment of human flcn and zebrafish flcn protein
sequence using Clustal Omega. The red box indicates the sequence and
ensuing stop codon that will be translated when the intron is retained in
embryos injected with flcn sp1 MO. (*) indicates positions which have a
single, fully conserved residue. (C) Long-pec stage embryo injected with
100 μM splice 1 mismatch morpholino (D) Long-pec stage embryo
injected with 100 μM splice 1 morpholino. (E) Long-pec stage 600 μM
ATG control morpholino injected embryos. (F) Long-pec stage 600 μM
flcn ATG morpholino injected embryo. (G) Fluorescent imaging of
Tg(wt1b:EGFP) transgenic zebrafish embryos injected with 100 μM splice
2 mismatch morpholino. (H) Fluorescent imaging of Tg(wt1b:EGFP)
transgenic zebrafish embryos injected with 100 μM flcn splice 2
morpholino (n = 8, 2 independent experiments). Images are of the
dorsal aspect behind the head region with the head positioned to
the left. gl, glomerulus; pt, pronephric tubule (I) Acetylated alpha
tubulin-cy3 staining of cilia in 100 μM splice 2 mismatch morpholino
injected Prim-5 stage embryos (J) Acetylated alpha tubulin antibody
staining of cilia in 100 μM splice 2 morpholino injected Prim-5 stage
embryos (n = 10, 2 independent experiments). Images are of the side
view of the trunk of the embryo. cc, central canal; pd, pronephric
duct. (TIF 13750 kb)
Additional file 2: Table S1. Absolute numbers of embryos after
injection with control, mismatch or flcn morpholinos. Columns show:
injection group - where each group was injected on a different day,
treatment group – where embryos were either uninjected, injected with
control MO, flcn ATG MO, flcn sp1 MO, flcn sp1 MM, flcn sp2 MO or flcn
sp2 MM, classification of embryos – showing the number of embryos
which are dead, normal or abnormal. (XLSX 8 kb)
Abbreviations
dpf: days post fertilization; hpf: hour post fertilization; LOF: loss of function;
MM: mismatch; MO: morpholino antisense oligonucleotides.
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